Examkin

Question

Difficulty: HardImmunologic and Inflammatory Processes

A 52-year-old woman presents to the clinic complaining of severe fatigue, generalized joint aches, and a new rash on her lower extremities that appeared 33 days ago. She has a history of intravenous drug use in her twenties but states she has been abstinent for over two decades. On physical examination, her temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 145/90 mm Hg145/90 \text{ mm Hg}, and pulse is 82/min82/\text{min}. Examination of the legs reveals non-blanching, erythematous macules and papules that coalesce into plaques. Laboratory studies reveal the following:

Laboratory ParameterValue
Hemoglobin11.2 g/dL11.2 \text{ g/dL}
Platelets180,000/mm3180,000/\text{mm}^3
Serum creatinine1.6 mg/dL1.6 \text{ mg/dL}
Aspartate aminotransferase (AST)85 U/L85 \text{ U/L}
Alanine aminotransferase (ALT)102 U/L102 \text{ U/L}
Hepatitis C virus RNA1,500,000 IU/mL1,500,000 \text{ IU/mL}
Complement C395 mg/dL95 \text{ mg/dL} (Normal: 80−16080-160)
Complement C44 mg/dL4 \text{ mg/dL} (Normal: 15−4515-45)
Rheumatoid factorPositive

Urinalysis shows 2+2+ protein, 15−2015-20 red blood cells/hpf, and occasional red blood cell casts. Which of the following best describes the fundamental immunopathologic mechanism responsible for this patient's cutaneous and renal findings?

  1. Vascular deposition of immune complexes containing monoclonal IgM directed against the Fc portion of IgGAnswer
  2. B
    Endothelial injury secondary to autoantibodies targeting proteinase-3 within neutrophil primary granules
  3. C
    Subendothelial accumulation of polymeric IgA1 and structurally abnormal O-linked glycans
  4. D
    Widespread consumption of complement components driven by a genetic deficiency of C1 esterase inhibitor
  5. E
    Direct cytotoxic T-lymphocyte mediated destruction of virally infected capillary endothelial cells

Answer

Vascular deposition of immune complexes containing monoclonal IgM directed against the Fc portion of IgG
The correct answer identifies the underlying pathophysiology of Type II mixed cryoglobulinemia. In patients with chronic Hepatitis C, continuous immune stimulation can lead to the production of monoclonal IgM antibodies that possess Rheumatoid Factor activity. Rheumatoid Factor is defined as an autoantibody (usually IgM) directed against the Fc portion of human IgG. These IgM-IgG-HCV immune complexes precipitate in cold temperatures (cryoglobulins) and deposit in the vascular endothelium of the skin, joints, and kidneys. This Type III hypersensitivity reaction intensely activates the classical complement pathway, leading to significant consumption of C4 (which is often profoundly low) while C3 may remain normal or mildly decreased.

Step-by-Step Solution

1
Synthesize the clinical presentation.
The patient has palpable purpura, arthralgias, and glomerulonephritis (RBC casts, elevated creatinine) in the setting of untreated chronic Hepatitis C infection.
Identifying the clinical triad and the underlying infectious trigger focuses the differential diagnosis on extrahepatic manifestations of HCV.
2
Analyze the immunologic laboratory profile.
The laboratory profile shows a markedly low C4 with a normal C3, alongside a positive Rheumatoid Factor.
Classical complement pathway activation strongly consumes C4. A positive Rheumatoid Factor in a patient without Rheumatoid Arthritis, combined with isolated low C4 and HCV, points directly to mixed cryoglobulinemia.
3
Determine the molecular mechanism of the identified disease.
Type II mixed cryoglobulinemia is characterized by the formation of immune complexes composed of polyclonal IgG and a monoclonal IgM antibody that acts as a Rheumatoid Factor (targeting the Fc portion of the IgG).
Understanding the exact composition of the cryoglobulins is required to select the correct immunopathologic mechanism.

Key Concept

Type II mixed cryoglobulinemia is a Type III hypersensitivity reaction strongly associated with Hepatitis C, characterized by immune complexes of polyclonal IgG and monoclonal IgM (Rheumatoid Factor) that activate the classical complement pathway, leading to low C4 levels, palpable purpura, and glomerulonephritis.
Estimated Time:2m 0s
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic